Search
Descriptor English: Solifenacin Succinate
Descriptor Spanish: Succinato de Solifenacina
Descriptor succinato de solifenacina
Scope note: Derivado de la quinuclidina y tetrahidroisoquinolina y ANTAGONISTA MUSCARÍNICO M3 selectivo. Se utiliza como AGENTE UROLÓGICO en el tratamiento de la INCONTINENCIA URINARIA.
Descriptor Portuguese: Succinato de Solifenacina
Descriptor French: Succinate de solifénacine
Entry term(s): 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-
905, YM
Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate
Solifenacin
Succinate, Solifenacin
Vesicare
YM 905
YM905
Tree number(s): D03.605.687.900
D03.633.100.531.820.594
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069464
Scope note: A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Muscarinic Antagonists
Urological Agents
Registry Number: KKA5DLD701
Public MeSH Note: 2016; SOLIFENACIN SUCCINATE was indexed under QUINUCLIDINES and TETRAHYDROISOQUINOLINES 2003-2015; and under ISOQUINOLINES 2001-2003
History Note: 2016 (2001)
DeCS ID: 55933
Unique ID: D000069464
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/09
Revision Date: 2016/05/31
Solifenacin Succinate - Preferred
Concept UI M0554458
Scope note A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE.
Preferred term Solifenacin Succinate
Entry term(s) Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate
Succinate, Solifenacin
YM905 - Narrower
Concept UI M0407673
Preferred term YM905
Entry term(s) 905, YM
YM 905
Vesicare - Narrower
Concept UI M0554595
Preferred term Vesicare
Solifenacin - Broader
Concept UI M0407671
Preferred term Solifenacin
Entry term(s) 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))-



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey